Simulations Plus, Inc.
NASDAQ:SLPMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $374.16M
- Beta
- 1.32
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.12
Volume 0.00M
Average 0.35M
SLP Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Simulations Plus, Inc.NASDAQ: SLP
Stock-Based Compensation · Q2 FY2026 · quarter ended Feb 2026
Stock-based compensation declines year over year
Q2 FY2026 stock-based compensation of $1.62M fell 4.1% year over year, ahead of the -7.5% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +27.9% a year.
Context
- Stock-based compensation amounted to 8.0% of revenue in FY2025, down 1.3 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -4.1% holds above the trailing-twelve-month pace of -7.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 6.35M USD
- Year-over-year change
- -2.8%
- 4-year CAGR
- +23.3%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 6.35M | -2.8% |
| FY2024 | 2024-08-31 | 6.54M | +35.4% |
| FY2023 | 2023-08-31 | 4.83M | +59.0% |
| FY2022 | 2022-08-31 | 3.04M | +10.4% |
| FY2021 | 2021-08-31 | 2.75M | — |
Stock-Based Compensation vs competitors
How SLP compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -7.5% is the 4th highest of 11, against a peer median of -16.9%.
- Stock-based compensation amounts to 7.7% of revenue for SLP, versus a peer median of 10.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $38.65M USD | -23.4% | +20.1% | 0.7% | |
| LTM Mar 2026 | $27.05M USD | -9.3% | -7.2% | 11.4% | |
| LTM Mar 2026 | $8.5M USD | -48.8% | — | 10.5% | |
| LTM Mar 2026 | $7.23M USD | -27.7% | -23.8% | 6.7% | |
| LTM Mar 2026 | $7.02M USD | -5.4% | +66.3% | — | |
| LTM Feb 2026 | $6.18M USD | -7.5% | +27.9% | 7.7% | |
| LTM Mar 2026 | $4.8M USD | -10.4% | +88.7% | 125.0% | |
| LTM Mar 2026 | $4.75M USD | +867.2% | +40.3% | 3.4% | |
| LTM Mar 2026 | $3.96M USD | +43865.8% | +2.1% | 101.0% | |
| LTM Dec 2025 | CHF 2.68M CHF | -42.8% | — | 75.0% | |
| LTM Mar 2026 | $1.28M USD | -60.6% | — | 1.9% | |
| Peer median (excluding SLP) | — | -16.9% | +20.1% | 10.5% | |
Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Net Income | 9.78M | 12.48M | 9.96M | 9.95M | (64.72M) |
| Depreciation & Amortization | 3.59M | 3.57M | 3.84M | 5.67M | 8.21M |
| Deferred Income Tax | (628K) | (270K) | (2.1M) | (1.77M) | (5.43M) |
| Stock-Based Compensation | 2.75M | 3.04M | 4.83M | 6.54M | 6.35M |
| Change in Working Capital | 974K | (2.62M) | 5.1M | (4.21M) | (2.59M) |
| Accounts Receivables | (2.43M) | (3.94M) | 4.1M | 3.13M | (581K) |
| Inventory | 3.15M | 0 | 0 | 0 | 0 |
| Accounts Payables | 39K | (162K) | (81K) | (477K) | (132K) |
| Other Working Capital | 210K | 1.48M | 1.09M | (6.86M) | (1.87M) |
| Other Non-Cash Items | 2.74M | 1.7M | 219K | (2.86M) | 76.29M |
| Operating Cash Flow | 19.2M | 17.9M | 21.86M | 13.32M | 18.13M |
| Capital Expenditures | (4.58M) | (3.97M) | (4.27M) | (566K) | (713K) |
| Acquisitions (Net) | 2.95M | 3.15M | (8.22M) | (98.77M) | 0 |
| Purchases of Investments | (122.4M) | (100.85M) | (95.05M) | (67.16M) | (6.5M) |
| Sales of Investments | 100.23M | 109.12M | 114.91M | 116.27M | 15.01M |
| Other Investing Activities | (2.95M) | (3.15M) | (3.82M) | (3.74M) | (4.24M) |
| Investing Cash Flow | (26.74M) | 4.31M | 7.37M | (53.97M) | 3.56M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 1.46M | 891K | 0 | 731K | 430K |
| Common Stock Repurchased | 0 | 0 | (20M) | 0 | 0 |
| Dividends Paid | (4.81M) | (4.85M) | (4.81M) | (4.8M) | 0 |
| Other Financing Activities | (1.33M) | (3.67M) | 1.54M | (2.5M) | (1.58M) |
| Financing Cash Flow | (4.68M) | (7.62M) | (23.27M) | (6.57M) | (1.15M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (12.22M) | 14.58M | 5.96M | (47.21M) | 20.54M |
| Free Cash Flow | 14.63M | 13.93M | 17.58M | 12.75M | 17.41M |
Simulations Plus, Inc.
NASDAQ:SLP
Intrinsic Alpha fair value
Locked
Current Price
$18.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.